Member Info for lukehere

We could be up and running again here next week.

That's so funny pwak,for I used to have a graph of the Tyratech SP stuck on the kitchen wall,which I had to take down when it fell below 1.75 pence and off the bottom of my chart. Now that the share price is hopefully back on the up maybe it will return,along with the cash which had, of necessity ,become a taboo subject. Nevertheless,I never for one moment lost faith in TYRU and my wife understands the ups and downs of investment;just not quite how far we plumbed recently.

Are holders heading for the exit door ? Is Byotrol looking at delisting ? Why should revenues do anything but fall now that future Solvay payments seem to be off the table. A look at the adverse P&L account ,built up over too many years, tells you all that you need to know about Byotrol's lack of success in commercialising their "technology".

I believe that if your KIN holding had a value of �1,000 at the time of suspension it will be worth �200 at the time of any relist.This of course ignores any premium or discount that the Market accords to the new entity.

Agreed warbrother666,for the trend line on the SP chart is clearly heading northwards,whilst the MMs were very reluctant to part with stock on Friday. No wonder though when one considers the progress that TyraTech is making across many fronts.

Our CEO had this to say two months ago:- Strategic Review "As well as focusing on ongoing operations, the Company has been conducting a comprehensive strategic review of its assets and growth options. The Board announced in May that it was intending to divide the Company's intellectual property and products into two separate entities, focused on human health and animal health respectively. A more detailed update will be given to shareholders in due course and it is expected that the reorganization of the Company will be completed by the end of the year." I believe that there are very many strands to this review and I would therefore not be surprised to see it extended beyond the year end.We are due a trading update in February which should be informative.News might of course break before that. Sorry warbrother666 that I cannot be more helpful.

A hard Brexit,leading to renewed sterling weakness, could prove helpful to Stilo. Without this,figures for 2017 could compare badly with those of 2016,with revenues and cash likely to decline. How investors,long term or otherwise,will react remains to be seen. The SP reflects this,having steadily fallen over many months and it might well continue to do so.

Revenues last year included," a single very significant payment on one specific development contract with Solvay." With a similar payment unlikely in the current 12 months,possibly Byotrol will be faced with gaping holes in its cash generation and revenue columns together with a reversal in any move towards profitability. No doubt the BOD will utter reassuring statements.Nevertheless I can see nothing attractive for potential investors. The share price is reflecting this and could well retreat further over coming months.

Potentially,warbrother666,those contracts will be announced to coincide with any conclusion of the ongoing strategic review,along with(possibly)details of new partnerships,financing,disposals,etc; or even an outright total sale. Whatever the outcome,it looks as though TyraTech is about to change its "shape",hopefully to the benefit of shareholders.

Several significant buys were logged on Friday afternoon,possibly emanating from the same source Could it be that the impact of the strategic review is becoming evident to those close to TyraTech ? Further buying next week allied to another upward price movement would be significant. Definitely exciting times ahead for this most promising of micro caps.

That is true lospeculatore. Although not on the same scale,the recent stake increase by CriSeren was interesting for their investments have proven very successful in recent times. The conclusion of Allenby Capital in last months TyraTech research note was pretty bullish. "It is clear that TyraTech is achieving a great deal with limited recources and could do much more if it wasn't undercapitalised." http://allenbycapital.com/research/research-tyratech_23_903670869.pdf This under capitalisation could become a thing of the past following any outcome of the current strategic review.

We have seen it all before on AIM. A company with huge potential,yet the shares languish near multi year lows;prior to their surging upwards as potential translates into burgeoning progress. For me,Tyratech is the epitome of such a situation. Our CEO has spelt out where the future lies and even put a time scale in place. Nevertheless, the share price together with any interest in Tyratech remains moribund. Possibly then,now would be a good time to invest or to add,for that "surge" cannot be too far ahead.

Who put up that amount in 24 hours flat via the now completed accelerated bookbuild ? Hopefully those with assets and or a plan which they can reverse into this shell. NW1 and the concert party for example.

lospeculatore Possibly the winner more suggested a serious product from a serious company. Just how serious should become evident over the next six months or so. I believe that the recent signs of life ,displayed by the share price,are a precursor of more significant upward movements lying ahead. "All" we need is a successful and rewarding outcome to the strategic review,a strong final half from Human Health allied to news of initial contracts with those global egg/chicken producers along with increasing revenues from our existing Animal Health products. All feasibly achievable imo.

Preparing for launch by the looks of things,and showing initiative,via the lowest possible cost option. https://label.designcrowd.com/contest.aspx?id=1684073

had this to say on your query,a few days ago,JESK. Trials, by nature, are not usually income generating and can take time. In simple terms field trials are loss leaders to validate the efficacy of the product in the real world. Once proven and adopted - that's when we will start to see the returns ramp up. After almost 2 years of field trials, Bruno has intimated that we are very close to entering the next phase. And that's why there is a company structure review taking place to be in the best position to manage what will be rapid expansion in production and distribution. Exciting times.

Extracted from the TyraTech 2016 Final Results, "The Company is currently working with the biggest producers of eggs in the US (Cal-Maine Foods Inc.; Rose Acre Farms Inc.) as well as with the biggest producers of breeder and broiler chickens (Tyson Foods Inc.; Perdue Food). " Extracted from Google, "Cal-Maine Foods Inc. is the largest egg producer in the U.S. and the world. As of December 31, 2016, the company’s layer flock included 37.94 million hens. " "Rose Acre Farms Inc. is a family-owned egg farm and is the second largest egg producer in the U.S. and the third largest egg producer in the world. " "No. 1-ranked Tyson Foods, the largest producer of broiler chicken in the U.S." Surely there is very significant value to be gained from investmenting in TyraTech,for,imo,their future looks exceeding promising.

Although the TyraTech share price has demonstrated relative strength through the first half of September,I do believe that the SP will move faster and further on an upward trajectory than investors might be expecting. If ivyspivey proves correct in her thinking that Human Health is set for disposal,then Vamousse in particular might ensure that a good price is obtained.Based either on its net contribution or purely revenues, whilst also having regard for the potential for these to be increased, there is reason to expect any sale price to exceed US$12million,or roughly double the present market cap. In this event,should the TyraTech BOD subsequently provide detail as to their plans for the Animal Health division,then shareholders (and others)will suddenly have a clear view of what I am sure will be a future brimming with profitable opportunities. In these circumstances ,I would expect to see the SP moving towards 4.5 pence;a level from which we might see further solid,maybe spectacular,progress. Exciting times indeed.

A 50% spread for TYRU and one of 40% for TYR is a sure sign that the MMs are running scared. I agree with you,ivyspivey ,that fireworks lie ahead. Possibly before November 5th.

Thanks for your posts. I believe that those invested in TyraTech have much to look forward to.